YCY
NYSE · N/A
Aa Mission Acquisition-A
$10.26
+0.00 (+0.00%)
Open$10.26
Previous Close$10.26
Day High$10.26
Day Low$10.26
52W High$10.30
52W Low$9.90
Volume—
Avg Volume20.6K
Market Cap120.86M
P/E Ratio97.45
EPS$0.07
SectorN/A
Key Financials
| FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|
| Revenue | 39.01M | 40.32M | 32.67M |
| Net Income | 1.80M | 2.30M | 1.57M |
| Profit Margin | 4.6% | 5.7% | 4.8% |
| EBITDA | 3.33M | 3.18M | 2.52M |
| Free Cash Flow | 1.88M | 2.00M | 1.33M |
| Rev Growth | +9.1% | -6.2% | +4.8% |
| Debt/Equity | 0.57 | 0.61 | 0.48 |
N/A Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| EMAT | Evolution Metals & Technolog | $2.07 | -3.94% | — | 1.28B |
| PICS | Pics Nv | $8.97 | +6.41% | 4.6 | 1.18B |
| DMII | Drugs Made In America Acquis | $10.19 | +0.00% | 49.9 | 649.10M |
| CCCX | Churchill Capital Corp X-A | $10.08 | -5.62% | — | 2.32B |
| BEAG | Bold Eagle Acquisition Cor-A | $10.70 | +0.19% | 42.2 | 335.10M |
| CEPF | Cantor Equity Partners-Cl A | $10.27 | +0.00% | 41.3 | 586.93M |